Long‐term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies

Background and Objectives We evaluated the outcome of pelvic exenteration in women with locally advanced primary or recurrent gynecological malignancies. Methods All pelvic exenteration procedures performed between 01/2003 and 06/2009 were evaluated. Extent of surgical radicality, operative techniques, and outcome were evaluated. Kaplan–Meier curves were calculated for Overall (OS) and progression‐free survival (PFS). Results Forty‐seven patients (median age: 52.5 years) were evaluated. Ten of 47 patients (21.3%) had a primary and 37(78.7%) a relapsed cancer. Most common (80.8%) site of origin was the cervix. Patients (80.8%) had undergone previous pelvic irradiation. A total exenteration was performed in 32/47 patients (68%). A complete tumor resection was obtained in 23 patients (49%). Thirty‐three patients (70.2%) had at least one major complication, including ileus (8.5%), intestinal‐fistula (29.8%), ureteral anastomotic insufficiency (6.4%), abscess (6.4%), and cardiothrombotic events (23.4%). At a median follow‐up of 7 months (range: 1–42), 22/47 patients (46.8%) died and 22/47 (46.8%) experienced a relapse. Median OS was 4 months (range: 0.1–16) and 22 months (range: 6–42) for patients with versus without postoperative tumor residuals, respectively ( P  = 0.0006), while median PFS was 4 months (range:0.1–16) versus 12months (range: 6–42) ( P  < 0.0001). Conclusions Radical pelvic exenteration due to advanced pelvic malignancies may be associated with a high morbidity. Complete tumor resection is associated with a significantly higher overall and PFS. J. Surg. Oncol. 2010; 101:507–512. © 2010 Wiley‐Liss, Inc.